Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akemi Ohno

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 12, 2015
[Evolution of urine test paper]Akemi Ohno
Annals of Clinical Biochemistry|March 18, 2021
Assessment of humoral responses in COVID-19 using various quantitative antibody testsMasatoshi Wakui, Yoshifumi Uwamino, Toshinobu Kurafuji, et al.
Vaccines|July 30, 2025
Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster ShotsYoshifumi Uwamino, Takashi Yokoyama, Yasunori Sato, et al.
Vaccine|February 2, 2023
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccineYoshifumi Uwamino, Takashi Yokoyama, Yasunori Sato, et al.
Vaccine|June 19, 2022
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccineYoshifumi Uwamino, Toshinobu Kurafuji, Kumiko Takato, et al.
Vaccine|January 16, 2022
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staffYoshifumi Uwamino, Toshinobu Kurafuji, Yasunori Sato, et al.
European Journal of Immunology|October 17, 2022
Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assayMasatoshi Wakui, Yoshifumi Uwamino, Yoko Yatabe, et al.
Cell Genomics|March 5, 2025
Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicityKyuto Sonehara, Yoshifumi Uwamino, Ryunosuke Saiki, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 12, 2015
[Evolution of urine test paper]Akemi Ohno
Annals of Clinical Biochemistry|March 18, 2021
Assessment of humoral responses in COVID-19 using various quantitative antibody testsMasatoshi Wakui, Yoshifumi Uwamino, Toshinobu Kurafuji, et al.
Vaccines|July 30, 2025
Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster ShotsYoshifumi Uwamino, Takashi Yokoyama, Yasunori Sato, et al.
Vaccine|February 2, 2023
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccineYoshifumi Uwamino, Takashi Yokoyama, Yasunori Sato, et al.
Vaccine|June 19, 2022
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccineYoshifumi Uwamino, Toshinobu Kurafuji, Kumiko Takato, et al.
Vaccine|January 16, 2022
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staffYoshifumi Uwamino, Toshinobu Kurafuji, Yasunori Sato, et al.
European Journal of Immunology|October 17, 2022
Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assayMasatoshi Wakui, Yoshifumi Uwamino, Yoko Yatabe, et al.
Cell Genomics|March 5, 2025
Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicityKyuto Sonehara, Yoshifumi Uwamino, Ryunosuke Saiki, et al.
Pageof 1